| Literature DB >> 17561995 |
Thomas Guillemette1, Noël N M E van Peij, Theo Goosen, Karin Lanthaler, Geoffrey D Robson, Cees A M J J van den Hondel, Hein Stam, David B Archer.
Abstract
BACKGROUND: Filamentous fungi such as Aspergillus niger have a high capacity secretory system and are therefore widely exploited for the industrial production of native and heterologous proteins. However, in most cases the yields of non-fungal proteins are significantly lower than those obtained for fungal proteins. One well-studied bottleneck appears to be the result of mis-folding of heterologous proteins in the ER during early stages of secretion, with related stress responses in the host, including the unfolded protein response (UPR). This study aims at uncovering transcriptional and translational responses occurring in A. niger exposed to secretion stress.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17561995 PMCID: PMC1894978 DOI: 10.1186/1471-2164-8-158
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1GeneChip results were confirmed for some genes using Northern blotting and RT-PCR. Examples are provided for both Northern blots (A) and RT-PCR (B). Note that the RT-PCR for the hacA mRNA was designed to indicate enhanced splicing of the hacA mRNA intron under stress conditions (DTT, tunicamycin and production of t-PA). This is shown as a relative increase in the amount of the processed (lower band) hacAform of the mRNA compared to the unprocessed higher band (hacA). Probing or PCR for an actin gene was used as a non-stress-responsive control transcript.
Genes induced by at least 2 treatments.
| DSM code | Predicted protein | ||||
| An18g02020 | Protein disulfide isomerase TIGA | *1.3 ± 0.5 | 1.7 ± 0.4 | *1.7 ± 0.03 | 1.8 ± 0.02 |
| An11g11250 | similar to the chaperone P58IPK | 2.5 ± 0.6 | 1.9 ± 0.07 | *1.3 ± 0.3 | 1.5 ± 0.05 |
| An05g00880 | similar to dnaJ protein homolog SCJ1 | 2.5 ± 0.3 | 1.5 ± 0.06 | 2.1 ± 0.3 | *1.6 ± 0.2 |
| An01g13070 | similar to ER protein-translocation complex subunit SEC63 | *1.3 ± 0.5 | 1.6 ± 0.09 | *1.7 ± 0.2 | 2.5 ± 0.1 |
| An16g08830 | similar to component of subcomplex SEC71 | 1.8 ± 0.2 | *1.4 ± 0.08 | 1.9 ± 0.4 | *1.7 ± 0.04 |
| An17g00090 | similar to translocation complex subunit SEC72 | 1.7 ± 0.2 | 1.6 ± 0.2 | 2.1 ± 0.5 | *1.3 ± 0.1 |
| An01g11630 | similar to translocation complex component SSS1 | 2.5 ± 0.2 | 1.6 ± 0.3 | 1.6 ± 0.04 | *1.6 ± 0.1 |
| An01g00560 | similar to signal peptidase subunit SEC11 | 2.2 ± 0.4 | 1.9 ± 0.06 | *1.1 ± 0.2 | 1.7 ± 0.009 |
| An15g06470 | similar to signal sequence receptor α-subunit | 1.8 ± 0.6 | 1.5 ± 0.07 | *1.5 ± 0.4 | 1.5 ± 0.08 |
| An14g05910 | similar to mannosyltransferase ALG2 | 2.3 ± 0.5 | *2.9 ± 1.1 | *1.7 ± 0.2 | 1.5 ± 0.1 |
| An18g02360 | similar to mannosyltransferase ALG3 | 2.4 ± 0.4 | 4.8 ± 2.1 | *-1.4 ± 0.3 | 2.0 ± 0.3 |
| An02g03240 | similar to N-acetylglucosaminephosphotransferase ALG7 | 1.8 ± 0.3 | 2.8 ± 0.5 | 2.1 ± 0.1 | *1.7 ± 0.2 |
| An07g04190 | similar to glycosyltransferase WBP1 | 1.9 ± 0.2 | 1.8 ± 0.09 | *1.4 ± 0.2 | 1.7 ± 0.09 |
| An02g14560 | oligosaccharyltransferase alpha subunit OSTA | 1.7 ± 0.09 | 1.6 ± 0.06 | *-1.4 ± 0.007 | 1.6 ± 0.4 |
| An18g03920 | similar to oligosaccharyltransferase subunit OST2 | 1.9 ± 0.4 | 1.5 ± 0.2 | 1.5 ± 0.1 | *1.2 ± 0.2 |
| An18g06220 | similar to alpha-mannosidase MNS1 | *1.1 ± 0.5 | 2.4 ± 0.6 | *1.2 ± 0.004 | 1.8 ± 0.1 |
| An13g00620 | similar to beta subunit of an ER alpha-glucosidase | *1.4 ± 0.5 | 1.9 ± 0.2 | *-1.8 ± 0.1 | 1.7 ± 0.2 |
| An15g01420 | similar to glucosidase I CWH41 | *1.3 ± 0.5 | 1.7 ± 0.5 | *-1.8 ± 0.2 | 1.6 ± 0.01 |
| An04g05250 | similar to dolichol synthesis protein RER2 | 1.7 ± 0.1 | *1.3 ± 0.08 | 2.2 ± 0.1 | *1.2 ± 0.1 |
| An02g14940 | similar to flippase RFT1 | *1.5 ± 0.5 | *-1.0 ± 0.9 | 1.7 ± 0.1 | 1.7 ± 0.1 |
| An01g04320 | similar to COPII vesicle coat component protein ERV46 | 2.1 ± 0.2 | 2.4 ± 0.3 | *1.5 ± 0.1 | 2.1 ± 0.05 |
| An02g04250 | similar to ER protein P58 (lectin family) | 1.7 ± 0.5 | 1.8 ± 0.2 | *1.2 ± 0.01 | 1.5 ± 0.3 |
| An02g08450 | secretory gene product NSFA | 1.5 ± 0.2 | *1.2 ± 0.006 | 2.5 ± 0.06 | *1.1 ± 0.06 |
| An08g06780 | similar to ER to Golgi transport protein USO1 | 2.0 ± 0.1 | *6.5 ± 3.2 | 5.3 ± 3.6 | *1.7 ± 0.6 |
| An16g06750 | similar to D-stereospecific aminopeptidase | *2.0 ± 0.5 | 2.1 ± 0.1 | 14.0 ± 8.0 | *2.1 ± 0.2 |
| An08g09000 | similar to ubiquitin like protein DSK2 | 1.7 ± 0.4 | *1.0 ± 0.1 | 3.0 ± 0.2 | *-1.1 ± 0.2 |
| An09g00950 | similar to aminopeptidase DAP | 1.6 ± 0.2 | *-1.7 ± 0.3 | 6.2 ± 1.4 | *1.1 ± 0.2 |
| An11g02990 | similar to cytochrome P450 DIT2 | *-1.2 ± 0.5 | *1.2 ± 0.002 | 2.0 ± 0.3 | 1.6 ± 0.03 |
| An14g07030 | similar to carboxylesterase | *1.6 ± 0.5 | *-1.9 ± 1.2 | 43.0 ± 5.3 | 1.7 ± 0.2 |
| An12g03150 | similar to multidrug resistance protein ATRD | 2.0 ± 0.4 | *-1.1 ± 0.3 | 10.1 ± 2.5 | *-1.1 ± 0.1 |
| An14g06610 | similar to elongation factor Eef1 alpha-A chain TEF2 | 1.6 ± 0.1 | *1.6 ± 0.3 | 8.6 ± 1.3 | *1.4 ± 0.3 |
| An12g03580 | similar to glutathione S-transferase 3 MGST3 | *1.2 ± 0.5 | *1.3 ± 0.1 | 3.2 ± 0.5 | 5.1 ± 1.4 |
| An01g14100 | weakly similar to stress protein HERP Mus musculus | 2.0 ± 0.1 | *1.5 ± 0.2 | 1.5 ± 0.3 | *1.8 ± 0.3 |
| An01g08170 | similar to DNA repair endonuclease RAD1 | 1.8 ± 0.5 | *1.8 ± 0.2 | 2.2 ± 1.1 | *1.6 ± 0.2 |
| An09g06400 | similar to chitinase CHIA | -2.1 ± 0.5 | *1.0 ± 0.008 | 2.4 ± 0.3 | 2.3 ± 0.8 |
| An16g09070 | similar to glucosamine-6-phosphate deaminase | *-1.2 ± 0.5 | *1.4 ± 0.2 | 2.1 ± 0.08 | 2.4 ± 0.7 |
| An02g00120 | hypothetical protein | *2.4 ± 0.5 | *1.2 ± 0.3 | 2.0 ± 0.5 | 1.8 ± 0.07 |
| An08g03970 | hypothetical protein | *1.7 ± 0.5 | 2.0 ± 0.4 | *1.2 ± 0.02 | 1.8 ± 0.1 |
| An09g00650 | hypothetical protein | 2.0 ± 0.3 | *-1.30.4 | 2.7 ± 0.2 | 4.0 ± 1.4 |
| An17g00660 | hypothetical protein | *-1.1 ± 0.2 | *-1.5 ± 0.6 | 5.0 ± 2.7 | 1.6 ± 0.1 |
| An11g06970 | hypothetical protein | *3.1 ± 0.3 | *1.7 ± 0.7 | 17.3 ± 6.0 | 2.3 ± 0.6 |
| An16g00070 | hypothetical protein | *-1.4 ± 0.5 | *1.1 ± 0.1 | 5.1 ± 0.1 | 1.5 ± 0.2 |
| An16g08470 | hypothetical protein | *1.8 ± 0.3 | *1.1 ± 0.2 | 1.5 ± 0.1 | 1.5 ± 0.05 |
| An02g14500 | hypothetical protein | *-1.2 ± 0.4 | *1.0 ± 0.1 | 9.3 ± 2.7 | 1.7 ± 0.1 |
| An03g00720 | hypothetical protein | *1.1 ± 0.5 | *-1.2 ± 0.06 | 2.6 ± 1.1 | 1.9 ± 0.7 |
| An04g02250 | questionable ORF | *2.2 ± 0.3 | 2.0 ± 0.2 | 20.2 ± 10.3 | *1.3 ± 0.006 |
| An14g01990 | hypothetical protein | 3.0 ± 0.4 | *-1.4 ± 0.2 | 4.3 ± 0.9 | *-1.1 ± 0.03 |
| An08g04260 | hypothetical protein | 2.0 ± 0.6 | *1.7 ± 0.3 | 2.4 ± 0.01 | *1.3 ± 0.07 |
| An07g10280 | hypothetical protein | 2.0 ± 0.7 | *1.6 ± 0.08 | 1.8 ± 0.9 | *1.6 ± 0.2 |
| An09g06130 | hypothetical protein | 2.0 ± 0.3 | *2 ± 0.2 | 1.6 ± 0.4 | *1.4 ± 0.09 |
| An08g09860 | hypothetical protein | 2.3 ± 0.6 | *1.2 ± 0.4 | 7.4 ± 1.0 | *-1.4 ± 0.1 |
| An18g06120 | similar to secreted protein vc33_1 | 1.9 ± 0.2 | *-1.1 ± 0.1 | 2.2 ± 0.1 | *1.0 ± 0.05 |
| An14g06550 | hypothetical protein | 2.1 ± 0.3 | *1.2 ± 0.1 | 2.8 ± 0.6 | *1.2 ± 0.1 |
| An15g02650 | hypothetical protein | 2.8 ± 1.5 | *1.1 ± 0.2 | 2.8 ± 0.6 | *1.1 ± 0.1 |
| An11g10800 | similar to probable isochorismatase | 2.3 ± 0.3 | *1.0 ± 0.002 | 11.5 ± 2.2 | *1.2 ± 0.2 |
| An18g01690 | hypothetical protein | 2.3 ± 1.5 | *2.1 ± 0.5 | 2.4 ± 0.9 | *1.1 ± 0.1 |
| An16g08680 | hypothetical protein | 1.7 ± 0.4 | *-1.1 ± 0.2 | 6.7 ± 0.5 | *1.1 ± 0.07 |
The fold changes in expression are indicated for all the treatments (Tun = tunicamycin, DTT = dithiothreitol, tPA = production of t-PA) and are averaged over two experiments. Similarities are expressed in comparison with the Saccharomyces cerevisiae genome except when indicated. The symbol* indicates that the value does not meet one of the 3 restrictive criteria defined in the Method section. The genes induced by the three treatments are marked in bold.
Genes repressed by at least 2 treatments.
| DSM code | Predicted protein | ||||
| An12g05960 | similar to dipeptidyl peptidase II DPPII | *1.3 ± 0.5 | *1.6 ± 0.2 | -1.9 ± 0.3 | -1.5 ± 0.6 |
| An03g01660 | similar to vacuolar aminopeptidase Y APE3 | -2.1 ± 0.3 | *1.0 ± 0.05 | -1.7 ± 0.7 | *1.1 ± 0.02 |
| An03g05200 | similar to carboxypeptidase S1 | -2.1 ± 0.4 | *1.1 ± 0.4 | -1.8 ± 0.6 | *-1.4 ± 0.08 |
| An04g01440 | similar to vacuolar aspartyl protease PEP4 | -2.1 ± 0.3 | *1.1 ± 0.2 | -1.6 ± 0.04 | *-1.3 ± 0.03 |
| An08g08750 | carboxypeptidase Y CPY | -1.9 ± 0.2 | *1.0 ± 0.06 | -2.2 ± 0.02 | *-1.3 ± 0.04 |
| An14g00620 | similar to aminopeptidase | -2.4 ± 0.5 | *-1.0 ± 0.01 | -2.3 ± 0.1 | *-1.1 ± 0.2 |
| An16g01880 | similar to lysophospholipase | *-2.2 ± 0.5 | -1.7 ± 0.3 | -99.8 ± 5.6 | 1.4 ± 0.8 |
| An02g09540 | similar to choline permease HNM1 | *1.1 ± 0.5 | *1.0 ± 0.6 | -2.4 ± 0.9 | -1.9 ± 0.1 |
| An16g06090 | similar to choline permease HNM1 | *-1.3 ± 0.3 | *1.1 ± 0.01 | -1.9 ± 0.2 | -2.2 ± 0.5 |
| An15g06810 | similar to cytochrome-b5 reductase MCR1 | *1.1 ± 0.2 | *1.6 ± 0.1 | -1.7 ± 0.3 | -2.6 ± 011 |
| An01g03350 | similar to C-8 sterol isomerase ERG1 | -1.9 ± 0.3 | *1.2 ± 0.2 | -2.1 ± 0.6 | *-1.2 ± 0.3 |
| An02g03580 | similar to lipid metabolism protein ERG28 | -1.8 ± 0.2 | *1.2 ± 0.02 | -2.0 ± 0.2 | *-1.3 ± 0.06 |
| An01g07000 | similar to C-14 sterol reductase ERG24 | -1.7 ± 0.1 | *1.2 ± 0.2 | *3.9 ± 0.4 | -1.9 ± 0.08 |
| An16g03370 | similar to protein involved in of cell wall biogenesis CWH43 | -2.0 ± 0.2 | *1.2 ± 0.1 | -2.4 ± 0.1 | *-1.2 ± 0.01 |
| An16g07040 | similar to cell wall glucanase SCW10 | -1.7 ± 0.1 | *-1.1 ± 0.07 | -4.0 ± 0.5 | *-1.0 ± 0.04 |
| An04g00990 | NADP-dependent glutamate dehydrogenase GDHA | *1.1 ± 0.3 | *-3.5 ± 2.0 | -3.6 ± 0.7 | -1.5 ± 0.005 |
| An16g01610 | similar to hydroxylase BBH | *-1.2 ± 0.5 | -2.5 ± 0.7 | -13.5 ± 0.1 | *-1.0 ± 0.5 |
| An01g14730 | similar to lactonizing enzyme I TcMLE | -1.6 ± 0.1 | *-1.3 ± 0.1 | -1.5 ± 0.2 | *1.3 ± 0.2 |
| An02g00190 | similar to enantiomer-selective amidase AMDA | -2.9 ± 0.5 | *1.1 ± 0.2 | -2.3 ± 0.3 | *-1.3 ± 0.5 |
| An12g10000 | similar to GABA permease GABA | *-1.0 ± 0.08 | *1.0 ± 0.1 | -5.5 ± 1.9 | -1.8 ± 0.09 |
| An12g01910 | similar to phytase PHYA3 | -1.5 ± 0.1 | -1.6 ± 0.3 | -21.1 ± 2.5 | *-1.0 ± 0.1 |
| An09g00270 | alpha-galactosidase AGLC | *-1.2 ± 0.1 | -2.0 ± 0.5 | -5.9 ± 2.0 | *1.1 ± 0.3 |
| An09g00260 | alpha-galactosidase AGLC | *-2.6 ± 0.5 | -2.1 ± 0.3 | -6.0 ± 4.3 | *1.1 ± 0.2 |
| An01g01540 | similar to alpha.alpha-trehalase TREA | -3.0 ± 0.6 | *-1.1 ± 0.1 | -2.7 ± 0.6 | *1.2 ± 0.02 |
| An01g00780 | endo-1.4-xylanase XYNB | -3.4 ± 0.6 | *1.5 ± 0.4 | -4.3 ± 0.9 | *1.0 ± 0.1 |
| An05g00930 | similar to mitochondrial malic enzyme MAE1 | -2.1 ± 0.2 | *1.2 ± 0.1 | -4.0 ± 1.0 | *-1.0 ± 0.04 |
| An19g00090 | similar to exo-beta-1.3-glucanase CMG1 | -2.6 ± 0.3 | *1.6 ± 0.1 | -4.6 ± 1.0 | *3.7 ± 0.06 |
| An11g04780 | similar to protein involved in active glycerol uptake GUP1 | -1.7 ± 0.2 | *1.2 ± 0.2 | -2.4 ± 0.3 | *1.0 ± 0.1 |
| An01g04250 | similar to uroporphyrinogen decarboxylase HEM12 | *-1.2 ± 0.06 | *1.1 ± 0.04 | -1.6 ± 0.1 | -1.6 ± 0.1 |
| An12g10320 | similar to high-affinity zinc transport protein ZRT1 | *1.1 ± 0.05 | *1.4 ± 0.04 | -2.2 ± 0.04 | -3.2 ± 1.1 |
| An16g06740 | similar to cadmium resistance protein YCF1 | *-1.4 ± 0.2 | *-1.7 ± 0.5 | -1.7 ± 0.2 | -1.7 ± 0.3 |
| An07g00570 | similar to membrane protein PTH11 | *-1.1 ± 0.1 | *-1.0 ± 0.04 | -2.7 ± 0.06 | -2.0 ± 0.1 |
| An18g00980 | similar to membrane protein PTH11 | *-3.0 ± 0.5 | *1.4 ± 0.2 | -4.6 ± 0.2 | -2.0 ± 0.1 |
| An16g05920 | similar to membrane protein PTH11 | *1.1 ± 0.2 | -3.9 ± 1.1 | -5.5 ± 1.1 | *1.0 ± 0.08 |
| An10g00800 | similar to purine nucleoside permease NUP | -5.4 ± 0.8 | *-1.5 ± 0.07 | -31.9 ± 2.7 | *1.2 ± 0.1 |
| An18g01220 | similar to allantoate permease DAL5 | -1.6 ± 0.1 | *1.6 ± 0.2 | -4.2 ± 0.06 | *-1.2 ± 0.05 |
| An07g06530 | similar to multicopy suppressor SUR7 | *2.0 ± 0.4 | *1.7 ± 0.2 | -5.0 ± 1.9 | -1.6 ± 0.1 |
| An16g05910 | similar to putative cytochrome P450 | *-1.2 ± 0.08 | -2.3 ± 0.5 | -5.8 ± 0.2 | *2.2 ± 0.05 |
| An11g09870 | similar to palmitoleyltransferase ERF2 | -1.6 ± 0.1 | *1.4 ± 0.2 | -2.1 ± 0.3 | *1.0 ± 0.01 |
| An02g03570 | similar to membrane protein YBR159w | -2.1 ± 0.2 | *-1.3 ± 0.3 | *-1.9 ± 1.0 | -1.6 ± 0.2 |
| An11g07340 | similar to hypothetical O-methyl transferase ENCK | *1.3 ± 0.1 | *1.3 ± 0.5 | -4.2 ± 0.6 | -4.2 ± 1.7 |
| An12g09640 | similar to hypothetical GTP cyclohydrolase | *2.6 ± 0.5 | *1.3 ± 0.4 | -3.3 ± 0.2 | -1.9 ± 0.5 |
| An01g09220 | weakly similar to tyrosinase MELC2 | *-2.1 ± 0.5 | *2.1 ± 0.2 | -5.2 ± 1.7 | -1.8 ± 0.4 |
| An03g00770 | similar to allergic allergen rAsp f 4 | *-2.3 ± 0.6 | *-1.1 ± 0.3 | -2.6 ± 0.1 | -2.8 ± 0.6 |
| An08g03760 | hypothetical protein | *-1.1 ± 0.1 | *-1.3 ± 0.07 | -4.0 ± 1.8 | -2.4 ± 0.3 |
| An02g08330 | hypothetical protein | *1.2 ± 0.2 | *-17 ± 11.3 | 13.5 ± 5.2 | -1.8 ± 0.1 |
| An06g01000 | hypothetical protein | *-1.1 ± 0.1 | *-1.0 ± 0.05 | -1.83 ± 0.5 | -2.3 ± 0.1 |
| An11g07020 | hypothetical protein | *1.3 ± 0.3 | *1.2 ± 0.02 | -2.1 ± 0.3 | -1.8 ± 0.2 |
| An02g08300 | hypothetical protein | *2.2 ± 0.5 | *-1.7 ± 0.3 | -3.2 ± 0.8 | -8.6 ± 0.9 |
| An03g00840 | hypothetical protein | 1.8 ± 0.2 | *-1.2 ± 0.2 | *1.3 ± 0.1 | -2.4 ± 0.9 |
| An18g01000 | hypothetical protein | *-2.4 ± 0.5 | *1.1 ± 0.1 | -4.6 ± 0.5 | -1.8 ± 0.2 |
| An13g01520 | hypothetical protein | -1.5 ± 0.1 | *-2.9 ± 0.2 | *-1.0 ± 0.4 | -1.9 ± 0.2 |
| An02g00120 | hypothetical protein | -2.4 ± 0.5 | *1.2 ± 0.3 | -2.0 ± 0.5 | *-1.8 ± 0.07 |
| An04g01690 | hypothetical protein | -2.1 ± 0.4 | *-1.0 ± 0.3 | -3.1 ± 1.1 | *-1.1 ± 0.03 |
| An05g01770 | hypothetical protein | -1.5 ± 0.1 | *-1.5 ± 0.3 | -5.8 ± 1.0 | *1.0 ± 0.5 |
| An07g05160 | hypothetical protein | -1.7 ± 0.1 | *-1.2 ± 0.2 | -2.1 ± 0.05 | *1.0 ± 0.08 |
| An07g08400 | strong similarity to allergen rAsp f 4 | -1.8 ± 0.2 | *1.3 ± 0.2 | -4.2 ± 1.2 | *1.1 ± 0.07 |
| An08g08600 | similar to RTN2 | -1.9 ± 0.2 | *-1.0 ± 0.01 | -3.3 ± 0.6 | *-1.0 ± 0.1 |
| An12g10590 | hypothetical protein | -2.6 ± 0.4 | *1.1 ± 0.03 | -12.0 ± 2.1 | *1.0 ± 0.02 |
| An15g01740 | similar to ER protein of unknown function | -1.6 ± 0.1 | *1.4 ± 0.1 | -2.1 ± 0.3 | *1.0 ± 0.1 |
The fold changes in expression are indicated for all the treatments (Tun = tunicamycin, DTT = dithiothreitol, tPA = production of t-PA) and are averaged over two experiments. Similarities are expressed in comparison with the Saccharomyces cerevisiae genome except when indicated. The symbol* indicates that the value does not meet one of the 3 restrictive criteria defined in the Method section.
Figure 2Hierarchical clustering of records in a dendrogram (tree graph) based on the similarity of the signal log ratios obtained in each of the duplicate stress studies. Records (188) were selected based on differential expression in the tPA comparisons. This tree is representative for multiple clusterings performed using signals or signal log ratios. The genes have been rearranged into their cluster order and are represented on the vertical axis. The experiments are represented on the horizontal axis. The significance of the colour scale is indicated.
Figure 3Venn diagrams of the numbers of overlapping and non-overlapping induced (≥ 1.5 fold) or repressed (≤ 1.5 fold) genes on the A. niger array after exposure to DTT or tunicamycin (Tun) and in the t-PA producing strain (t-PA).
Figure 4(A) Representative absorbance profile for RNA separated by velocity sedimentation through a 15–60% sucrose gradient. Fractions are numbered from the top to the bottom of the gradient. (B) RNA was extracted from each fraction and subjected to electrophoresis through a formaldehyde gel. The ribosomal RNA distribution profile (25S, 18S and 5S rRNA; indicated by arrowheads) enables the the assignment of OD254 peaks, corresponding to the 40S and 60S ribosomal subunits and to intact ribosomes (80S). (C) RT-PCR analysis with hacA primers were performed from each fraction of collected gradients from treated and non-treated cells. The full length hacAmRNA (arrow) as well as low-molecular-weight version of hacA(arrowhead) can be visualized.
Examples of genes for which DTT treatment resulted in > 2 fold shift of transcripts from the non-polysomal to polysomal samples, or vice versa, relative to untreated controls.
| An09g05420 | similar to signal peptidase subunit SPC3 | 4.61 | 0.64 | 7.20 |
| An15g01130 | similar to brefeldin A resistance protein BFR1 ( | 0.79 | 0,26 | 3.04 |
| An01g14260 | similar to delta subunit of the coatomer delta-coat protein COPD ( | 1.79 | 0.68 | 2.63 |
| An17g00270 | similar to 26S ATP/ubiquitin-dependent proteinase chain S4 ( | 3.13 | 1.28 | 2.45 |
| An02g13840 | similar to cytoplasmic ribosomal protein of the small subunit S9 ( | 0.47 | 27.28 | 57.91 |
| An18g05810 | similarity to cytoplasmic ribosomal protein of the small subunit S26 ( | 0.51 | 11.22 | 22,03 |
| An08g00970 | ribosomal protein of the small subunit rps28 | 0.71 | 3.48 | 4.91 |
| An11g09570 | similar to cytoplasmic ribosomal protein of the large subunit L37.b | 0.57 | 8.33 | 14.62 |
| An12g04860 | similar to cytoplasmic ribosomal protein of the large subunit L30 | 0.37 | 4.18 | 11.42 |
| An01g02880 | similar to cytoplasmic ubiquitin/ribosomal fusion protein CEP52 | 0.67 | 4.61 | 6.92 |
| An18g04570 | similar to cleavage/polyadenylation factor IA subunit CLP1 | 0.71 | 1.56 | 2.20 |
| An02g09260 | similar to nucleolar protein NOP5 | 2.12 | 9.22 | 4.34 |
| An18g04840 | similar to elongation factor 1 alpha ( | 1.88 | 6.02 | 3.21 |
| An15g00750 | Similar to elongation factor 1-gamma 1 TEF3 | 2.16 | 5.35 | 2.47 |
| An07g02650 | similar to translation elongation factor 3 YE3 | 2.96 | 23.88 | 8.07 |
| An11g01760 | similar to proteasome 20S subunit PRE2 | 3.79 | 20.52 | 5.42 |
| An02g07010 | similar to ubiquitin UBI1 ( | 1.1 | 7.5 | 7.12 |
| An08g10110 | similar to lipid transfer protein POX18 ( | 0.96 | 4.04 | 4.23 |
| An03g06410 | similar to methyl sterol oxidase ERG25 | 1.23 | 2.84 | 2.32 |
| An12g01890 | similar to squalene synthase ERG9 ( | 1.01 | 2.21 | 2.18 |
| An02g10350 | similar to farnesyl-pyrophosphate synthase FPPS | 1.90 | 4.13 | 2.17 |
| An07g09570 | similar to phosphatidate cytidylyltransferase CDS1 | 0.84 | 1.73 | 2.06 |
| An03g02400 | similar to hydrophobin DEWA ( | 0.51 | 1.59 | 3.10 |
| An06g01550 | similar to glucan synthase FKS ( | 0.46 | 1.33 | 2.89 |
| An11g00270 | similar to lanosterol 14 alpha-demethylase CYP51 ( | 0.64 | 1.44 | 2.25 |
| An02g02360 | similar to chitin synthase ( | 0.43 | 0.96 | 2.24 |
| An12g01910 | similar to phytase PHYA3 ( | 0.36 | 4.03 | 11.1 |
| An03g06550 | Glucoamylase GLAA | 0.57 | 17.69 | 30.98 |
| An02g13220 | similar to lysophospholipase phospholipase B ( | 0.55 | 2.90 | 5.23 |
| An09g00270 | alpha-galactosidase AGLC | 0.38 | 1.65 | 4.3 |
| An02g01550 | similar to serine protease ( | 1.78 | 6.69 | 3.76 |
| An02g04690 | similar to serine-type carboxypeptidase I CDPS ( | 1.71 | 3.56 | 2.08 |
The DTT induced shift was determined by calculating (DTT treated polysomal/DTT treated non-polysomal)/(control polysomal/control non-polysomal).
Figure 5Model of the secretory pathway under different ER stress conditions (t-PA secretion, tunicamycin and DTT) together with examples of genes that are transcriptionally induced or repressed. The A. niger gene designation is provided where previously known or, otherwise, the S. cerevisiae gene name is provided. Red, genes up-regulated by 3 conditions; orange, genes up-regulated by 2 conditions; yellow, genes up-regulated by 1 condition; light blue, genes down-regulated by 1 condition; blue, genes down-regulated by 2 conditions. N, nucleus; ER, endoplasmic reticulum; E, endosome; V, vacuole; G, Golgi. ERAD is ER-associated degradation.
Primers for probe generation by PCR and for RT-PCR.
| Gene | Primer pairs | Amplicon size (bp) |
| 5'-CAGAGACAGGCCACCAAGGACGCT-3' 5'-CGAACTTGGCGCGGGTGAGGGTCT-3' | 445 | |
| 5'-TATCTTTGCCGAGACCAAGG-3' 5'-AACAGGTTCCGACTTGATGC-3' | 298 | |
| 5'-TGATACCGAGTCTGAGTTA-3' 5'-CTCGATTCTGTTTGCCTAGC-3' | 303 | |
| 5'-CGCATCCTACCCATACTCGT-3' 5'-GGAACCAGCGATTAGCAAAG-3' | 280 | |
| 5'-CTTCTCCTACCCTAACTCCT-3' 5'-TCAAAGAGAGAGAGGGCAC-3' | 397 | |
| 5'-GCCTTCTACGTCTCCATCCA-3' 5'-GAACAGAGCCTCAGGAGCAC-3' | 396 | |
| 5'-TCATGATCGGTATGGGTCAG-3' 5'-ACGATGTTGCCGTACAGATC-3' | 765 |
1: primers designed for blot probes
2: primers designed for RT-PCR